[1]
Anas Babar, “Comment on Khan S P Khan, et al. (J Pak Med Assoc. 74: 1654-1658, September 2024) Role of Oral Hypoglycaemic Drugs in Preventing Complications in Non-Alcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus”, J Pak Med Assoc, vol. 75, no. 02, pp. 349–349, Jan. 2025.